Hydroxychloroquine and chloroquine retinopathy: A systematic review evaluating the multifocal electroretinogram as a screening test

Ophthalmology

Volumn 122, Issue 6, 2015, Pages 1239-1251.e4

  Tsang, Adrian C ^a,b   Ahmadi Pirshahid, Sina ^a,b   Virgili, Gianni ^c   Gottlieb, Chloe C ^a,b,d   Hamilton, John ^a,d   Coupland, Stuart G ^a,b,d  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE; ANTIRHEUMATIC AGENT;

ARTICLE; AUTOMATED VISUAL FIELD; DIAGNOSTIC TEST ACCURACY STUDY; ELECTRORETINOGRAPHY; FUNDUS AUTOFLUORESCENCE; HUMAN; META ANALYSIS; MULTIFOCAL ELECTRORETINOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINOPATHY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; VISUAL FIELD; VISUAL SYSTEM PARAMETERS; CHEMICALLY INDUCED; FLUORESCENCE ANGIOGRAPHY; PROCEDURES; RETINAL DISEASES; VISION DISORDERS; VISION TEST;

ANTIRHEUMATIC AGENTS; CHLOROQUINE; ELECTRORETINOGRAPHY; FLUORESCEIN ANGIOGRAPHY; HUMANS; HYDROXYCHLOROQUINE; RETINAL DISEASES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISION SCREENING; VISUAL FIELDS;

EID: 84930040918     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2015.02.011     Document Type: Article

References (42)

1. P. Kumar, and S. Banik Pharmacotherapy options in rheumatoid arthritis Clin Med Insights Arthritis Musculoskelet Disord 6 2013 35 43
2. K. Rüther, J. Foerster, S. Berndt, and J. Schroeter Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses Ophthalmologe 104 2007 875 879
3. M.F. Marmor, U. Kellner, and T.Y.Y. Lai Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy Ophthalmology 118 2011 415 422
4. D.F. Stroup, J.A. Berlin, and S.C. Morton Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
5. M.A. Xiaoyun, H.E. Dongyi, and H.E. Linping Assessing chloroquine toxicity in RA patients using retinal nerve fibre layer thickness, multifocal electroretinography and visual field test Br J Ophthalmol 94 2010 1632 1636
6. R.V. Jivrajka, M.A. Genead, and J.J. McAnany Microperimetric sensitivity in patients on hydroxychloroquine (Plaquenil) therapy Eye (Lond) 27 2013 1044 1052
7. T.Y.Y. Lai, W.M. Chan, and H. Li Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy Am J Ophthalmol 140 2005 794 807
8. J.A. Rodriguez-Padilla, T.R. Hedges III, and B. Monson High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy Arch Ophthalmol 125 2007 775 780
9. R.K. Maturi, M. Yu, and R.G. Weleber Multifocal electroretinographic evaluation of long-term hydroxychloroquine users Arch Ophthalmol 122 2004 973 981
10. U. Kellner, A.B. Renner, and H. Tillack Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine Invest Ophthalmol Vis Sci 47 2006 3531 3538
11. S. Missner, and U. Kellner Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography Graefes Arch Clin Exp Ophthalmol 250 2012 319 325
12. P.J. Penrose, R.T. Tzekov, and E.E. Sutter Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine Retina 23 2003 503 512
13. S.C. So, T.R. Hedges, J.S. Schuman, and M.L. Quireza Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography Ophthalmic Surg Lasers Imaging 34 2003 251 258
14. M. Michaelides, N.B. Stover, P.J. Francis, and R.G. Weleber Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy Arch Ophthalmol 129 2011 30 39
15. W.H. Chang, B.J. Katz, and J.E. Warner A novel method for screening the multifocal electroretinogram in patients using hydroxychloroquine Retina 28 2008 1478 1486
16. M.F. Marmor Comparison of screening procedures in hydroxychloroquine toxicity Arch Ophthalmol 130 2012 461 469
17. S. Kellner, S. Weinitz, and U. Kellner Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence Br J Ophthalmol 93 2009 1444 1447
18. U. Kellner, H. Kraus, and M.H. Foerster Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction Graefes Arch Clin Exp Ophthalmol 238 2000 94 97
19. X. Ma, L. Yan, and L. He Ocular fundus manifestation of two patients following long-term chloroquine therapy: a case report Diagn Pathol 5 2010 20
20. U. Kellner, S. Kellner, and S. Weinitz Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography Doc Ophthalmol 116 2008 119 127
21. I. Ingster-Moati, E. Bui Quoc, and M. Crochet Severe chloroquine- and hydroxychloroquine-induced retinopathy J Fr Ophtalmol 29 2006 642 650
22. P. Salu, A. Uvijls, P. Van Den Brande, and B.P. Leroy Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up Doc Ophthalmol 120 2010 251 264
23. S.C. Teoh, J. Lim, and A. Koh Abnormalities on the multifocal electroretinogram may precede clinical signs of hydroxychloroquine retino-toxicity Eye (Lond) 20 2006 129 132
24. M.E. Gilbert, and P.J. Savino Missing the bull's eye Surv Ophthalmol 52 2007 440 442
25. R. Halfeld Furtado de Mendonca, O.O. Maia Jr., and W. Yukihiko Takahashi Electrophysiologic findings in chloroquine maculopathy Doc Ophthalmol 115 2007 117 119
26. H.K. Burnett, and R. Somani Clinically evident chloroquine toxicity undetected by multifocal electroretinogram Can J Ophthalmol 47 2012 31 33
27. V.C. Greenstein, L. Amaro-Quireza, and E.S. Abraham A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy Doc Ophthalmol 130 2015 13 23
28. D.J. Browning, and C. Lee Relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathy Clin Ophthalmol 8 2014 1389 1399
29. P.F. Whiting, A.W.S. Rutjes, and M.E. Westwood QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Ann Intern Med 155 2011 529 536
30. J.B. Reitsma, A.S. Glas, and A.W. Rutjes Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews J Clin Epidemiol 58 2005 982 990
31. C.A. Naaktgeboren, L.C. Bertens, and M. van Smeden Value of composite reference standards in diagnostic research BMJ 347 2013 f5605
32. J.S. Lyons, and M.L. Severns Using multifocal ERG ring ratios to detect and follow plaquenil retinal toxicity: a review Doc Ophthalmol 118 2009 29 36
33. J.S. Lyons, and M.L. Severns Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography Am J Ophthalmol 143 2007 801 809
34. D.C. Hood, L.J. Frishman, S. Saszik, and S. Viswanathan Retinal origins of the primate multifocal ERG: implications for the human response Invest Ophthalmol Vis Sci 43 2002 1673 1685
35. P. Glasziou, L. Irwig, and J.J. Deeks When should a new test become the current reference standard? Ann Intern Med 149 2008 816 821
36. M. Mititelu, B.J. Wong, and M. Brenner Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging JAMA Ophthalmol 131 2013 1187 1197
37. M.F. Marmor The dilemma of hydroxychloroquine screening: new information from the multifocal ERG Am J Ophthalmol 140 2005 894 895
38. M.N. Moschos, M.M. Moschos, and M. Apostolopoulos Assessing hydroxychloroquine toxicity by the multifocal ERG Doc Ophthalmol 108 2004 47 53
39. M.K. Adam, D.J. Covert, K.E. Stepien, and D.P. Han Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity Br J Ophthalmol 96 2012 723 729
40. M.F. Marmor, R.E. Carr, and M. Easterbrook Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology Ophthalmology 109 2002 1377 1382
41. C. Anderson, G.R. Blaha, and J.L. Marx Humphrey visual field findings in hydroxychloroquine toxicity Eye (Lond) 25 2011 1535 1545
42. P.M. Bossuyt, J.B. Reitsma, and D.E. Bruns The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration Ann Intern Med 138 2003 W1 12